Archive: 16/12/2012

Flaw in Alzheimer's drug trial test

New research led by Plymouth University Peninsula Schools of Medicine and Dentistry suggests that the cognitive test used in Alzheimer's drug trials is flawed.

Dec 16, 2012

Worries about dementia: How hospitalization affects the elderly

Older people often worry about dementia and while some risks are known, for example alcoholism or stroke, the effects of illness are less clear. New research published in BioMed Central's open access journal Critical Care ...

Dec 16, 2012

Changes in penile length after radical prostatectomy studied

(HealthDay)—Although penile shortening of about 1 cm can occur at three months after a radical prostatectomy (RP) for the treatment of localized prostate cancer, recovery of penile length begins after 24 months and is complete ...

Dec 16, 2012

0

0

Omega-3 supplements don't increase surgical blood loss

(HealthDay)—Omega-3 fatty acid (n-3FA) supplements do not correlate with higher perioperative blood loss during spinal fusion procedures, according to a study published in the December issue of the European Spine Journal.

Dec 16, 2012

2

0

UV nail lamps do not significantly up skin cancer risk

(HealthDay)—Ultraviolet (UV) nail lamps, used for professional and personal nail techniques, do not pose a clinically significant skin cancer risk, according to a letter to the editor published online Dec. 6 in the Journal ...

Dec 16, 2012

2

0

Winter weather, snow shoveling pose heart risks

(HealthDay)—As temperatures fall during the winter months, the risk for heart attacks rises for people with heart conditions and those engaging in rigorous physical activity.

Dec 16, 2012

1

0

Predictors of organ damage identified in patients with SLE

(HealthDay)—Patient age, hypertension, and corticosteroid use are the most important predictors of the cumulative organ damage that occurs in patients with systemic lupus erythematosus (SLE), according to research published ...

Dec 16, 2012

0

0

Iclusig approved for rare leukemias

(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..

Dec 16, 2012

0

0

Resistance to cocaine addiction may be passed down from father to son, study shows

Research from the Perelman School of Medicine at the University of Pennsylvania and Massachusetts General Hospital (MGH) reveals that sons of male rats exposed to cocaine are resistant to the rewarding effects of the drug, ...

Dec 16, 2012

Team studies role of white blood cells in kidney failure

Better targeted treatments for 20 per cent of renal failure patients are on the horizon following a key discovery about the role of white blood cells in kidney inflammation.

Dec 16, 2012

0

0

page 1 from 2

Archive: 16/12/2012

Flaw in Alzheimer's drug trial test

Worries about dementia: How hospitalization affects the elderly

Changes in penile length after radical prostatectomy studied

Omega-3 supplements don't increase surgical blood loss

UV nail lamps do not significantly up skin cancer risk

Winter weather, snow shoveling pose heart risks

Predictors of organ damage identified in patients with SLE

Iclusig approved for rare leukemias

Resistance to cocaine addiction may be passed down from father to son, study shows

Team studies role of white blood cells in kidney failure

Phys.org

Tech Xplore

Science X